RaySearch Launches RayIntelligence v2025 to Advance Oncology Data Analytics

RaySearch Laboratories AB (publ) has announced the release of RayIntelligence® v2025, a major update to its oncology analytics system aimed at transforming clinical data into actionable insights. The upgrade introduces new tools for customized dashboards and offers deeper integration across RaySearch’s product portfolio, including RayStation® and RayCare®, enabling clinics to continuously learn from patient journey data and improve treatment outcomes.

In many oncology centers, large volumes of clinical data remain fragmented across disparate systems, slowing the pace of evidence-based improvements. By directly connecting to primary oncology data sources, RayIntelligence helps institutions learn from their own datasets and adapt practices, assets, and skills on an ongoing basis.

According to the release, RayIntelligence v2025 allows clinics to design dashboards tailored to their operations and goals—whether tracking plan quality trends, machine utilization, protocol adherence, or outcome signals. The platform delivers a single, comprehensive intelligence layer to support the development of self-improving oncology programs, strengthening clinical readiness both now and in the future.

“Our vision for RayIntelligence has always been clear: to transform oncology data into a continuous source of insight. With v2025, we take a significant leap forward,” said Johan Löf, founder and CEO of RaySearch. “By absorbing and processing data from every stage of the patient journey, the system empowers clinics to refine their treatments and operations over time—building a smarter, more adaptive oncology program for the future.”